Parallax Volatility Advisers, L.P. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Parallax Volatility Advisers, L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $2.51 Million - $2.64 Million	-17,305 Reduced 86.51%	2,699 $408,000
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $1.66 Million - $2.92 Million	20,004 New	20,004 $2.91 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $15,260 - $24,364	-232 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$64.07 - $91.75 $1.56 Million - $2.23 Million	-24,330 Reduced 99.06%	232 $16,000
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $63,638 - $96,078	-978 Reduced 3.83%	24,562 $2.11 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $5.19 Million - $6.86 Million	-87,969 Reduced 77.5%	25,540 $1.66 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $3.27 Million - $8.37 Million	112,697 Added 13878.94%	113,509 $8.3 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $561,121 - $1.17 Million	-20,397 Reduced 96.17%	812 $28,000
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $1.3 Million - $2.19 Million	-32,640 Reduced 60.61%	21,209 $929,000
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $1.86 Million - $2.87 Million	53,830 Added 283315.78%	53,849 $2.77 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $565 - $815	19 New	19 $1,000
Q2 2018 Aug 14, 2018	SELL	$23.62 - $42.29 $298,863 - $535,095	-12,653 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $248,671 - $382,129	11,057 Added 692.79%	12,653 $326,000
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $32,622 - $56,753	1,596	1,596 $43,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.